NAMS
NewAmsterdam Pharma Company N.V.
21.30$
-3.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +40.7% | -8.6% | -1.7% | +96.9% | -5.3% | -0.4% | -3.5% | -2.2% | -4.8% | -3.8% | |
| – | – | +40.7% | -8.7% | -1.7% | +97.2% | -5.3% | -5.8% | -4.9% | -7.7% | -2.6% | +0.2% | |
| – | -18.7% | +41.3% | -10.5% | -1.9% | +82.6% | -3.0% | -24.7% | -4.5% | -9.0% | -6.6% | -7.3% | |
| – | -18.7% | +41.3% | -10.5% | -1.9% | +97.3% | -3.1% | -8.6% | -4.9% | -9.5% | 0.0% | -0.4% | |
| – | – | +119.7% | +21.9% | +2.2% | +314.0% | -92.4% | +1,124.4% | +2.5% | +14.3% | -64.5% | +191.9% | |
| – | – | – | -541,646,422.6% | – | – | – | – | – | – | – | – | |
| – | – | +185.9% | +11.5% | +9.4% | -9.9% | -6.0% | -6.4% | -6.6% | -7.3% | -7.9% | -8.5% | |
| – | – | +30.6% | -22.7% | +1.8% | +77.6% | -61.7% | -10.8% | +59.4% | +47.1% | -21.5% | +8.3% | |
| – | – | +19.7% | -24.1% | -8.9% | +159.2% | -61.7% | -10.8% | +59.6% | +47.2% | -21.4% | +8.2% | |
| – | – | -28.3% | +444.2% | +2.6% | +2.5% | +2.4% | -10.7% | -19.6% | -24.9% | -83.1% | +13.0% | |
| – | – | -49.6% | -38.2% | +33.4% | -32.6% | +28.3% | -3.2% | -38.4% | +147.0% | -9.8% | -33.0% | |
| – | -37.4% | +42.8% | -5.9% | -2.2% | +99.9% | +2.6% | +0.1% | -6.5% | -6.1% | -2.7% | -5.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +7.2% | +7.2% | +0.0% | +2.4% | +19.7% | -3.1% | +5.8% | -3.9% | +5.9% | +1.9% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.